Intra-articular Injection of HB-IGF-1 Sustains Delivery of IGF-1 to Cartilage through Binding to Chondroitin Sulfate

Objective: Insulin-like growth factor 1 (IGF-1) stimulates cartilage repair but is not a practical therapy due to its short half-life. We have previously modified IGF-1 by adding a heparin-binding domain and have shown that this fusion protein (HB-IGF-1) stimulates sustained proteoglycan synthesis...

Full description

Bibliographic Details
Main Authors: Miller, Rachel Elizabeth, Grodzinsky, Alan J., Cummings, Kiersten, Plaas, Anna H. K., Cole, Ada A., Lee, Richard T., Patwari, Parth
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Language:en_US
Published: Wiley Blackwell 2013
Online Access:http://hdl.handle.net/1721.1/76249
https://orcid.org/0000-0002-8911-7998
https://orcid.org/0000-0002-4942-3456
_version_ 1826191750504382464
author Miller, Rachel Elizabeth
Grodzinsky, Alan J.
Cummings, Kiersten
Plaas, Anna H. K.
Cole, Ada A.
Lee, Richard T.
Patwari, Parth
author2 Massachusetts Institute of Technology. Department of Biological Engineering
author_facet Massachusetts Institute of Technology. Department of Biological Engineering
Miller, Rachel Elizabeth
Grodzinsky, Alan J.
Cummings, Kiersten
Plaas, Anna H. K.
Cole, Ada A.
Lee, Richard T.
Patwari, Parth
author_sort Miller, Rachel Elizabeth
collection MIT
description Objective: Insulin-like growth factor 1 (IGF-1) stimulates cartilage repair but is not a practical therapy due to its short half-life. We have previously modified IGF-1 by adding a heparin-binding domain and have shown that this fusion protein (HB-IGF-1) stimulates sustained proteoglycan synthesis in cartilage. This study was undertaken to examine the mechanism by which HB-IGF-1 is retained in cartilage and to test whether HB-IGF-1 provides sustained growth factor delivery to cartilage in vivo and to human cartilage explants. Methods: Retention of HB-IGF-1 and IGF-1 was analyzed by Western blotting. The necessity of heparan sulfate (HS) or chondroitin sulfate (CS) glycosaminoglycans (GAGs) for binding was tested using enzymatic removal and cells with genetic deficiency of HS. Binding affinities of HB-IGF-1 and IGF-1 proteins for isolated GAGs were examined by surface plasmon resonance and enzyme-linked immunosorbent assay. Results: In cartilage explants, chondroitinase treatment decreased binding of HB-IGF-1, whereas heparitinase had no effect. Furthermore, HS was not necessary for HB-IGF-1 retention on cell monolayers. Binding assays showed that HB-IGF-1 bound both CS and HS, whereas IGF-1 did not bind either. After intraarticular injection in rat knees, HB-IGF-1 was retained in articular and meniscal cartilage, but not in tendon, consistent with enhanced delivery to CS-rich cartilage. Finally, HB-IGF-1 was retained in human cartilage explants but IGF-1 was not. Conclusion: Our findings indicate that after intraarticular injection in rats, HB-IGF-1 is specifically retained in cartilage through its high abundance of CS. Modification of growth factors with heparin-binding domains may be a new strategy for sustained and specific local delivery to cartilage.
first_indexed 2024-09-23T09:00:43Z
format Article
id mit-1721.1/76249
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T09:00:43Z
publishDate 2013
publisher Wiley Blackwell
record_format dspace
spelling mit-1721.1/762492022-09-26T09:47:49Z Intra-articular Injection of HB-IGF-1 Sustains Delivery of IGF-1 to Cartilage through Binding to Chondroitin Sulfate Miller, Rachel Elizabeth Grodzinsky, Alan J. Cummings, Kiersten Plaas, Anna H. K. Cole, Ada A. Lee, Richard T. Patwari, Parth Massachusetts Institute of Technology. Department of Biological Engineering Miller, Rachel Elizabeth Grodzinsky, Alan J. Objective: Insulin-like growth factor 1 (IGF-1) stimulates cartilage repair but is not a practical therapy due to its short half-life. We have previously modified IGF-1 by adding a heparin-binding domain and have shown that this fusion protein (HB-IGF-1) stimulates sustained proteoglycan synthesis in cartilage. This study was undertaken to examine the mechanism by which HB-IGF-1 is retained in cartilage and to test whether HB-IGF-1 provides sustained growth factor delivery to cartilage in vivo and to human cartilage explants. Methods: Retention of HB-IGF-1 and IGF-1 was analyzed by Western blotting. The necessity of heparan sulfate (HS) or chondroitin sulfate (CS) glycosaminoglycans (GAGs) for binding was tested using enzymatic removal and cells with genetic deficiency of HS. Binding affinities of HB-IGF-1 and IGF-1 proteins for isolated GAGs were examined by surface plasmon resonance and enzyme-linked immunosorbent assay. Results: In cartilage explants, chondroitinase treatment decreased binding of HB-IGF-1, whereas heparitinase had no effect. Furthermore, HS was not necessary for HB-IGF-1 retention on cell monolayers. Binding assays showed that HB-IGF-1 bound both CS and HS, whereas IGF-1 did not bind either. After intraarticular injection in rat knees, HB-IGF-1 was retained in articular and meniscal cartilage, but not in tendon, consistent with enhanced delivery to CS-rich cartilage. Finally, HB-IGF-1 was retained in human cartilage explants but IGF-1 was not. Conclusion: Our findings indicate that after intraarticular injection in rats, HB-IGF-1 is specifically retained in cartilage through its high abundance of CS. Modification of growth factors with heparin-binding domains may be a new strategy for sustained and specific local delivery to cartilage. National Institute of Biomedical Imaging and Bioengineering (U.S.) (Grant EB-003805) National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.) (Grant AR-045779) 2013-01-10T21:20:10Z 2013-01-10T21:20:10Z 2010-11 2010-04 Article http://purl.org/eprint/type/JournalArticle 0004-3591 1529-0131 http://hdl.handle.net/1721.1/76249 Miller, Rachel E. et al. “Intraarticular Injection of Heparin-binding Insulin-like Growth Factor 1 Sustains Delivery of Insulin-like Growth Factor 1 to Cartilage Through Binding to Chondroitin Sulfate.” Arthritis & Rheumatism 62.12 (2010): 3686–3694. https://orcid.org/0000-0002-8911-7998 https://orcid.org/0000-0002-4942-3456 en_US http://dx.doi.org/10.1002/art.27709 Arthritis and Rheumatism Creative Commons Attribution-Noncommercial-Share Alike 3.0 http://creativecommons.org/licenses/by-nc-sa/3.0/ application/pdf Wiley Blackwell PMC
spellingShingle Miller, Rachel Elizabeth
Grodzinsky, Alan J.
Cummings, Kiersten
Plaas, Anna H. K.
Cole, Ada A.
Lee, Richard T.
Patwari, Parth
Intra-articular Injection of HB-IGF-1 Sustains Delivery of IGF-1 to Cartilage through Binding to Chondroitin Sulfate
title Intra-articular Injection of HB-IGF-1 Sustains Delivery of IGF-1 to Cartilage through Binding to Chondroitin Sulfate
title_full Intra-articular Injection of HB-IGF-1 Sustains Delivery of IGF-1 to Cartilage through Binding to Chondroitin Sulfate
title_fullStr Intra-articular Injection of HB-IGF-1 Sustains Delivery of IGF-1 to Cartilage through Binding to Chondroitin Sulfate
title_full_unstemmed Intra-articular Injection of HB-IGF-1 Sustains Delivery of IGF-1 to Cartilage through Binding to Chondroitin Sulfate
title_short Intra-articular Injection of HB-IGF-1 Sustains Delivery of IGF-1 to Cartilage through Binding to Chondroitin Sulfate
title_sort intra articular injection of hb igf 1 sustains delivery of igf 1 to cartilage through binding to chondroitin sulfate
url http://hdl.handle.net/1721.1/76249
https://orcid.org/0000-0002-8911-7998
https://orcid.org/0000-0002-4942-3456
work_keys_str_mv AT millerrachelelizabeth intraarticularinjectionofhbigf1sustainsdeliveryofigf1tocartilagethroughbindingtochondroitinsulfate
AT grodzinskyalanj intraarticularinjectionofhbigf1sustainsdeliveryofigf1tocartilagethroughbindingtochondroitinsulfate
AT cummingskiersten intraarticularinjectionofhbigf1sustainsdeliveryofigf1tocartilagethroughbindingtochondroitinsulfate
AT plaasannahk intraarticularinjectionofhbigf1sustainsdeliveryofigf1tocartilagethroughbindingtochondroitinsulfate
AT coleadaa intraarticularinjectionofhbigf1sustainsdeliveryofigf1tocartilagethroughbindingtochondroitinsulfate
AT leerichardt intraarticularinjectionofhbigf1sustainsdeliveryofigf1tocartilagethroughbindingtochondroitinsulfate
AT patwariparth intraarticularinjectionofhbigf1sustainsdeliveryofigf1tocartilagethroughbindingtochondroitinsulfate